Cargando…
Lung Cancer Gene Signatures and Clinical Perspectives
Microarrays have been used for more than two decades in preclinical research. The tumor transcriptional profiles were analyzed to select cancer-associated genes for in-deep functional characterization, to stratify tumor subgroups according to the histopathology or diverse clinical courses, and to as...
Autor principal: | Kuner, Ruprecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003440/ https://www.ncbi.nlm.nih.gov/pubmed/27605195 http://dx.doi.org/10.3390/microarrays2040318 |
Ejemplares similares
-
Serum microRNAs as non-invasive biomarkers for cancer
por: Brase, Jan C, et al.
Publicado: (2010) -
Cross-talk between AMPK and EGFR dependent Signaling in Non-Small Cell Lung Cancer
por: Praveen, Paurush, et al.
Publicado: (2016) -
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018) -
Classification across gene expression microarray studies
por: Buness, Andreas, et al.
Publicado: (2009) -
Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives
por: Varnier, Romain, et al.
Publicado: (2021)